HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting.

AbstractBACKGROUND:
In recent years, many countries have experienced an increase in the prevalence of allergic rhinitis. No effective approach is currently available to prevent the onset of symptoms in allergic individuals. Pranlukast, a leukotriene receptor antagonist with a good safety and efficacy record for the management of allergic inflammation, may be appropriate for early intervention in the management of pollinosis.
OBJECTIVE:
To investigate the efficacy of pranlukast as an early intervention in the control of cedar pollinosis.
METHODS:
In a double-blind comparative study, pranlukast (n = 102) or placebo (n = 91) was administered to cedar pollinosis patients immediately before the start of the dispersion season and continued for 4 weeks. Subsequently, pranlukast was administered to all patients for 2 weeks until the end of the cedar pollen dispersion season (mid-March). All patients were carefully monitored for severity of nasal symptoms, symptom scores, medication scores, symptom-medication scores, and quality of life (QOL).
RESULTS:
Compared with placebo, therapy with pranlukast before and during the dispersion of cedar pollen in these patients significantly improved nasal symptoms (paroxysmal sneezing, rhinorrhea, and nasal congestion), symptom scores, and symptom-medication scores. The drug also significantly reduced deterioration of QOL, and improved nasal symptoms and QOL throughout the dispersion period.
CONCLUSION:
Administering pranlukast immediately before the beginning of cedar pollen dispersion is effective in reducing symptoms of allergic rhinitis throughout the dispersion period.
AuthorsS Yonekura, Y Okamoto, K Okubo, T Okawa, M Gotoh, H Suzuki, T Kakuma, S Horiguchi, T Hanazawa, A Konno, M Okuda
JournalJournal of investigational allergology & clinical immunology (J Investig Allergol Clin Immunol) Vol. 19 Issue 3 Pg. 195-203 ( 2009) ISSN: 1018-9068 [Print] Spain
PMID19610262 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromones
  • Leukotriene Antagonists
  • pranlukast
Topics
  • Adult
  • Chromones (administration & dosage, adverse effects, therapeutic use)
  • Cryptomeria (immunology)
  • Double-Blind Method
  • Female
  • Humans
  • Leukotriene Antagonists (administration & dosage, adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Pollen (immunology)
  • Quality of Life
  • Rhinitis, Allergic, Seasonal (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: